Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 11, 2020
Date Accepted: Jun 9, 2020

The final, peer-reviewed published version of this preprint can be found here:

Evaluation of More Stamina, a Mobile App for Fatigue Management in Persons with Multiple Sclerosis: Protocol for a Feasibility, Acceptability, and Usability Study

Giunti G, Rivera-Romero O, Kool J, Bansi J, Sevillano JL, Granja-Dominguez A, Izquierdo-Ayuso G, Giunta D

Evaluation of More Stamina, a Mobile App for Fatigue Management in Persons with Multiple Sclerosis: Protocol for a Feasibility, Acceptability, and Usability Study

JMIR Res Protoc 2020;9(8):e18196

DOI: 10.2196/18196

PMID: 32749995

PMCID: 7435635

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Pilot study for the evaluation of the More Stamina mobile application for fatigue management in persons with Multiple Sclerosis: Research protocol

  • Guido Giunti; 
  • Octavio Rivera-Romero; 
  • Jan Kool; 
  • Jens Bansi; 
  • Jose Luis Sevillano; 
  • Anabel Granja-Dominguez; 
  • Guillermo Izquierdo-Ayuso; 
  • Diego Giunta

ABSTRACT

Background:

Multiple sclerosis (MS) is one of the world’s most common neurologic disorders of the young adults leading to severe disability. MS Fatigue impacts directly on the quality of life and activity levels of people with MS. Self-management strategies are used to support them in the care of their health. Mobile health (mHealth) solutions can offer tools to help symptom management. Following a user-centered design and evidence-based process, a mHealth solution called More Stamina was created to help persons with MS manage their fatigue

Objective:

The overall study aims are to explore the feasibility, acceptability, and usability of More Stamina, a mobile app for fatigue self-management for persons with MS.

Methods:

A mixed methods multicenter study will be used to assess the feasibility, acceptability, and usability of More Stamina. The study will take place during the first and second quarters of 2020 (Q1-Q2 2020) in three locations: Argentina, Spain and Switzerland. A longitudinal cohort study will take place, along with think-aloud protocols, open-ended interviews and short answer questionnaires will be used. Persons with MS will be recruited from the different locations. This study seeks to enroll at least 20 patients that meet the criteria from each site for the longitudinal cohort study (total N=60).

Results:

Ethical approval has been granted in Argentina and is pending in Spain and Switzerland. Outcomes will be published in peer-reviewed medical journals and presented at international conferences.

Conclusions:

Findings from this study will be used to help understand the role that mHealth can play for fatigue management in MS. Clinical Trial: ClinicalTrials.gov NCT04244214; https://www.clinicaltrials.gov/ct2/show/NCT04244214


 Citation

Please cite as:

Giunti G, Rivera-Romero O, Kool J, Bansi J, Sevillano JL, Granja-Dominguez A, Izquierdo-Ayuso G, Giunta D

Evaluation of More Stamina, a Mobile App for Fatigue Management in Persons with Multiple Sclerosis: Protocol for a Feasibility, Acceptability, and Usability Study

JMIR Res Protoc 2020;9(8):e18196

DOI: 10.2196/18196

PMID: 32749995

PMCID: 7435635

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.